Patents by Inventor Guillaume BORREL

Guillaume BORREL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220335185
    Abstract: The present disclosure relates to a method comprising: receiving a resource model associated with a resource site and receiving one or more objective parameters, such that a first objective parameter comprised in the one or more objective parameters is a function of one or more parameter values of the resource model. The method comprises executing simulations to generate a first uncertainty value based on at least one of a first parameter value and a first uncertainty value of a first parameter of the resource model. The simulations may be executed to generate a first forecast uncertainty value for each scenario comprised in a plurality of scenarios. The method also identifies one service that minimizes an uncertainty value of the objective parameter based on the forecast uncertainty value. The method further includes generating a first visualization comprising the one identified service for viewing by a user via a user interface.
    Type: Application
    Filed: September 4, 2020
    Publication date: October 20, 2022
    Inventors: Morten Kristensen, Marie LeFranc, Bertrand Theuveny, Hadrien Dumont, Nikita Chugunov, Sebastien Roche, Wiwin Yuliana, Zhenning Bao, Erwan Olliero, Ram Sunder Kalyanraman, Thomas Pfeiffer, Claude Signer, Simon Edmundson, Hua Yu, Ke Jiang, Vassilis Varveropoulos, Henri-Pierre Valero, Eric Jeanson, Guillaume Borrel, Pierre Bettinelli, Joel Le Calvez
  • Publication number: 20220243575
    Abstract: The present disclosure relates to a system that is operable to receive an execution plan and execute a control operation on one or more equipment based operations within the execution plan. The one or more operations may include a data capturing operation associated with a resource site. In one embodiment, the system may be operable to execute at least a first operation in response to a success variable of the data capturing operation indicating a successful execution of the data capturing operation. The first operation may include a quality control operation that is executed by comparing at least one characteristic of the captured data to an expected characteristic to generate quality state data. The quality state data may have one of an acceptable status and an undesirable status. In response to the quality state data indicating an acceptable status for the quality control operation, executing at least a second operation.
    Type: Application
    Filed: September 4, 2020
    Publication date: August 4, 2022
    Inventors: Morten Kristensen, Marie LeFranc, Bertrand Theuveny, Hadrien Dumont, Nikita Chugunov, Sebastien Roche, Wiwin Yuliana, Zhenning Bao, Erwan Olliero, Ram Sunder Kalyanraman, Thomas Pfeiffer, Claude Signer, Simon Edmundson, Hua Yu, Ke Jiang, Vassilis Varveropoulos, Henri-Pierre Valero, Eric Jeanson, Guillaume Borrel, Pierre Bettinelli, Joel Le Calvez
  • Patent number: 10238695
    Abstract: Composition containing a microorganism, preferably an Archaea, expressing a TMA methyltransferase and a TMA methyl group acceptor corrinoid protein, capable of metabolizing trimethylamine (TMA) in the presence of hydrogen in a human cavity, such as the intestine or the vagina, for use as a medicament for treating, reducing or eliminating TMA at the level of the human cavity. In addition, a composition containing a TMA methyltransferase and a TMA methyl group acceptor corrinoid protein. These compositions are of use for treating trimethylaminuria, for treating vaginal fluids in the case of bacterial vaginosis and for reducing or eliminating odours due to TMA. These compositions are also of use for reducing the level of plasma TMAO, for preventing the formation of atheroma plaques and/or for preventing cardiovascular diseases.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: March 26, 2019
    Assignee: UNIVERSITE D'AUVERGNE CLERMONT I
    Inventors: Jean-François Brugere, Guillaume Borrel, Paul William O'Toole, Corinne Malpuech-Brugere, Monique Alric
  • Publication number: 20160074440
    Abstract: Composition containing a microorganism, preferably an Archaea, expressing a TMA methyltransferase and a TMA methyl group acceptor corrinoid protein, capable of metabolizing trimethylamine (TMA) in the presence of hydrogen in a human cavity, such as the intestine or the vagina, for use as a medicament for treating, reducing or eliminating TMA at the level of the human cavity. In addition, a composition containing a TMA methyltransferase and a TMA methyl group acceptor corrinoid protein. These compositions are of use for treating trimethylaminuria, for treating vaginal fluids in the case of bacterial vaginosis and for reducing or eliminating odours due to TMA. These compositions are also of use for reducing the level of plasma TMAO, for preventing the formation of atheroma plaques and/or for preventing cardiovascular diseases.
    Type: Application
    Filed: September 27, 2013
    Publication date: March 17, 2016
    Inventors: Jean-François BRUGERE, Guillaume BORREL, Paul William O'TOOLE, Corinne MALPUECH-BRUGERE, Monique ALRIC